Fund Essentials

Net Assets
$871M
Expense Ratio
-
Dividend Yield (Current)
-
Holdings
0
Inception Date
-
Fund Family
TEKLA HEALTHCARE INVESTORS
Asset Class
••••••••••
Legal Structure
••••••••••

Performance

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
GILDGilead Sciences Inc6.44%
AMGNAmgen Inc5.97%
REGNRegeneron Pharmaceuticals Inc5.91%
VRTXVertex Pharmaceuticals Inc3.96%
LLYEli Lilly & Co3.57%
Top 10 Concentration: 38.59%
Download all 102 holdings for HQH
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

HQH ETF Overview

HQH ETF (TEKLA HEALTHCARE INVESTORS) is managed by TEKLA HEALTHCARE INVESTORS with $870.6M in net assets. sectors including Unknown.

HQH performance shows data across multiple time periods..

HQH top holdings include Gilead Sciences Inc (6.4%), Amgen Inc (6.0%), Regeneron Pharmaceuticals Inc (5.9%), Vertex Pharmaceuticals Inc (4.0%), Eli Lilly & Co (3.6%). View all HQH holdings, sector breakdown, or dividend history.

HQH can be compared against other funds using the overlap calculator or side-by-side comparison tool. HQH alternatives are available via the screener, along with tax-loss harvesting opportunities.

Top 10 Holdings (38.6% of portfolio)

#TickerNameSectorWeight
1GILDGilead Sciences IncUnknown6.44%
2AMGNAmgen IncUnknown5.97%
3REGNRegeneron Pharmaceuticals IncUnknown5.91%
4VRTXVertex Pharmaceuticals IncUnknown3.96%
5LLYEli Lilly & CoUnknown3.57%
6BMRNBioMarin Pharmaceutical IncUnknown2.92%
7ALNYAlnylam Pharmaceuticals IncUnknown2.77%
8UNHUnitedHealth Group IncUnknown2.77%
9GVMXXState Street Global AdvisorsUnknown2.23%
10ABTAbbott LaboratoriesUnknown2.05%